Russian invasion of Ukraine could impact over 200 clinical studies
Many biotech and pharmaceutical companies have ongoing clinical trials in Ukraine, and the war in the country could delay drug development.
by CHRISTIAN BUNDGAARD, translated by daniel pedersen
The war in Ukraine is undoubtedly affecting many people’s lives, and many have already abandoned their homes as Russian troops edge closer to the country’s capital, Kyiv.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
